Premium
Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long term follow‐up
Author(s) -
Schleich Jean M.,
Bernard du Haut Cilly François,
Laurent Marie C.,
Almange Claude
Publication year - 2000
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/1097-0223(200006)20:6<449::aid-pd852>3.0.co;2-f
Subject(s) - in utero , medicine , amiodarone , fetus , ventricular tachycardia , cardiology , term (time) , tachycardia , pregnancy , biology , genetics , atrial fibrillation , physics , quantum mechanics
Fetal cardiac arrhythmias are one of the causes of intra‐uterine congestive heart failure and non‐immune hydrops fetalis leading to fetal death. As ventricular tachycardia (VT) is rarely diagnosed in utero , it leads to emergency deliveries. We report a prenatal diagnosis of fetal tachycardia at 20 weeks of gestation associated with non‐immune hydrops fetalis. The tachycardia seemed to be supraventricular and was initially treated by digoxin and sotalol. The hydrops increased and sotalol was stopped in order to give the mother a high dose of amiodarone by mouth over a long period. Although the tachycardia, which the ECG recorded at birth revealed to be of ventricular origin, persisted but at a lower rate, the new treatment proved successful. The child is three years old now and health, though with persistent VT. In conclusion, fetal tachycardia with similar ventricular and atrial rates can be a VT and the drug of choice in this case seems to be amiodarone. Copyright © 2000 John Wiley & Sons, Ltd.